All In Biotech

Drug Trial Radar · NCT01104792

Long-term Study of Cariprazine in Patients With Schizophrenia

Evaluation of the Long-term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia

Last checked: Nov 20, 2026Latest source record: Jul 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

752

Actual

Start

May 31, 2010

Primary completion

Jan 31, 2013

Study completion Jan 31, 2013

Sponsor

Lead sponsor
Forest LaboratoriesAbbVie (ABBV)
Sponsor type
Industry
Collaborators
Gedeon Richter Ltd.
First posted
Apr 15, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.

Conditions

  • Schizophrenia

Interventions

  • CariprazineDrug

    Cariprazine was supplied in capsules.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 48 in the PANSS Total ScoreTime frame: Baseline to Week 48

Locations

86 sites in 6 countries. Site status is shown where the registry gives one.

  • Forest Investigative Site 072

    Little Rock, Arkansas

  • Forest Investigative Site 021

    Little Rock, Arkansas

  • Forest Investigative Site 086

    Little Rock, Arkansas

  • Forest Investigative Site 014

    Springdale, Arkansas

  • Forest Investigative Site 080

    Carson, California

  • Forest Investigative Site 079

    Cerritos, California

  • Forest Investigative Site 048

    Costa Mesa, California

  • Forest Investigative Site 070

    Costa Mesa, California

  • Forest Investigative Site 022

    Garden Grove, California

  • Forest Investigative Site 083

    Garden Grove, California

  • Forest Investigative Site 050

    Long Beach, California

  • Forest Investigative Site 006

    Oceanside, California

  • Forest Investigative Site 003

    Riverside, California

  • Forest Investigative Site 016

    San Diego, California

  • Forest Investigative Site 073

    Santa Ana, California

  • Forest Investigative Site 071

    New Britain, Connecticut

  • Forest Investigative Site 002

    Bradenton, Florida

  • Forest Investigative Site 041

    Kissimmee, Florida

  • Forest Investigative Site 082

    North Miami, Florida

  • Forest Investigative Site 055

    Atlanta, Georgia

  • Forest Investigative Site 087

    Atlanta, Georgia

  • Forest Investigative Site 012

    Honolulu, Hawaii

  • Forest Investigative Site 018

    Chicago, Illinois

  • Forest Investigative Site 008

    Hoffman Estates, Illinois

  • Forest Investigative Site 044

    Rockville, Maryland

  • Forest Investigative Site 007

    Flowood, Mississippi

  • Forest Investigative Site 017

    Creve Coeur, Missouri

  • Forest Investigative Site 076

    Saint Charles, Missouri

  • Forest Investigative Site 045

    St Louis, Missouri

  • Forest Investigative Site 052

    Las Vegas, Nevada

  • Forest Investigative Site 004

    Willingboro, New Jersey

  • Forest Investigative Site 040

    Cedarhurst, New York

  • Forest Investigative Site 019

    Willoughby, Ohio

  • Forest Investigative Site 077

    Philadelphia, Pennsylvania

  • Forest Investigative Site 047

    Philadelphia, Pennsylvania

  • Forest Investigative Site 074

    Austin, Texas

  • Forest Investigative Site 084

    DeSoto, Texas

  • Forest Investigative Site 043

    Irving, Texas

  • Forest Investigative Site 078

    Bellevue, Washington

  • Forest Investigative Site 602

    Bogotá, Colombia

Showing 40 of 86 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.